These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39391122)

  • 1. Radioactive Iodine Treatment of Graves' Disease: Predictors of Time Interval Greater than 90 Days for Treatment Success.
    Joya LE; Fogel J; Mandal K; Rosenthal DS
    J Community Hosp Intern Med Perspect; 2024; 14(4):6-11. PubMed ID: 39391122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioactive Iodine Therapy of Graves' Disease in Patients Pretreated With Methimazole Without Radioiodine Uptake for Dose Estimation.
    Mihailescu DV; Hoscheit C; Fogelfeld L
    Endocr Pract; 2024 Apr; 30(4):333-339. PubMed ID: 38307459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
    Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
    Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
    Kaplowitz PB; Jiang J; Vaidyanathan P
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated
    Wong KK; Shulkin BL; Gross MD; Avram AM
    Clin Diabetes Endocrinol; 2018; 4():20. PubMed ID: 30505461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study.
    Park H; Kim HI; Park J; Park SY; Kim TH; Chung JH; Choi JY; Kim SW
    Nucl Med Commun; 2020 Mar; 41(3):212-218. PubMed ID: 31895759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
    Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Prolonged Euthyroidism After Radioactive Iodine Treatment for Graves' Disease: A Pilot Study.
    Lu JY; Chen KH; Shih SR; Wen FY; Wu WC; Chen TC; Hu FC
    Endocr Pract; 2023 Feb; 29(2):89-96. PubMed ID: 36396015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves' Disease.
    Park SH; Hwang S; Han S; Shin DY; Lee EJ
    Int J Endocrinol; 2017; 2017():7354673. PubMed ID: 29358949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioactive Iodine: A Living History.
    Daniels GH; Ross DS
    Thyroid; 2023 Jun; 33(6):666-673. PubMed ID: 37307104
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioactive iodine treatment for Graves' hyperthyroidism: incidence of Graves orbitopathy.
    Quah NQX; Sobti MM; Wren AM; Scawn R; Kalogianni E; Cleland J; Maenhout A
    Nucl Med Commun; 2024 Feb; 45(2):103-107. PubMed ID: 37982569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F; Giovannetti C; Fessehatsion R; Tanda ML; Campomori A; Compri E; Rossi G; Ceccarelli C; Vitti P; Pinchera A; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jan; 95(1):201-8. PubMed ID: 19906789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cold iodine in patients with Graves' disease: observations from a clinical practice.
    Hao ST; Reasner CA; Becker RA
    Endocr Pract; 2001; 7(6):438-42. PubMed ID: 11747279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age moderates the associations between TRAbs, free T3 and outcomes of Graves' disease patients with radioactive iodine treatment.
    Lu L; Gao C; Zhang N
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):303-309. PubMed ID: 32734611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adjunctive use of carbimazole during radioactive iodine treatment reduces the cure rate of Graves' disease.
    Docrat F; Mokoena T; Karusseit VOL; Ankrah AO
    S Afr Med J; 2021 Feb; 111(2):176-179. PubMed ID: 33944730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients.
    Lee SW; Lee J; Bae JH; Seo JH; Kang SM; Ahn BC; Lee I
    Nucl Med Commun; 2009 Apr; 30(4):275-80. PubMed ID: 19252454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of previous administration of potassium iodine and different durations of low iodine diets for radioiodine therapy on the treatment of Graves' disease in iodine-rich areas.
    Tamura M; Nakada K; Iwanaga H; Fujita N; Kato K
    Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1060-1069. PubMed ID: 38008728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for hypothyroidism in Graves' disease.
    Verdickt S; Van Nes F; Moyson C; Maes T; Van Crombrugge P; Van den Bruel A; Decallonne B
    Eur Thyroid J; 2022 Aug; 11(4):. PubMed ID: 35687484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.